Meeting of the Chronic Fatigue Syndrome Advisory Committee, 61706 [2011-25739]

Agencies

• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 76, Number 193 (Wednesday, October 5, 2011)]
[Notices]
[Page 61706]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-25739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Chronic Fatigue Syndrome Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health, Office on 
Women's Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a 
meeting. The meeting will be open to the public.

DATES: The meeting will be held on Tuesday, November 8, 2011 and 
Wednesday, November 9, 2011. The meeting will be held from 9 a.m. to 5 
p.m. on November 8, 2011, and 9 a.m. to 4:30 p.m. on November 9, 2011.

ADDRESSES: Holiday Inn Capitol; Columbia Room; 550 C Street, SW., 
Washington, DC 20024; Hotel (202-479-4000).

FOR FURTHER INFORMATION CONTACT: Nancy C. Lee, MD; Designated Federal 
Officer, Chronic Fatigue Syndrome Advisory Committee, Department of 
Health and Human Services; 200 Independence Avenue, SW., Hubert 
Humphrey Building, Room 712E; Washington, DC 20201. Please direct all 
inquiries to cfsac@hhs.gov.

SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002. 
The Committee shall advise and make recommendations to the Secretary, 
through the Assistant Secretary for Health, on a broad range of topics 
including (1) The current state of knowledge and research and the 
relevant gaps in knowledge and research about the epidemiology, 
etiologies, biomarkers and risk factors relating to CFS, and 
identifying potential opportunities in these areas; (2) impact and 
implications of current and proposed diagnosis and treatment methods 
for CFS; (3) development and implementation of programs to inform the 
public, health care professionals, and the biomedical academic and 
research communities about CFS advances; and (4) partnering to improve 
the quality of life of CFS patients.
    The agenda for this meeting is being developed. The agenda will be 
posted on the CFSAC Web site, https://www.hhs.gov/advcomcfs, when it is 
finalized. The meeting will be recorded and archived for on-demand 
viewing through the CFSAC Web site. It will be available by audio on 
both days and the call-in numbers will be posted on the CFSAC Web site.
    Public attendance at the meeting is open. Those attending the 
meeting will need to sign-in prior to entering the meeting room. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the designated contact person at cfsac@hhs.gov in advance.
    Members of the public will have the opportunity to provide oral 
testimony on both days of the meeting; pre-registration for oral 
testimony is required. Individuals who wish to address the Committee 
during the public comment session must pre-register by Wednesday, 
October 26, 2011, via e-mail to cfsac@hhs.gov. Time slots for public 
comment will be available on a first-come, first-served basis and will 
be limited to five minutes per speaker; no exceptions will be made. 
Priority will be given to individuals who have not presented public 
comment at previous CFSAC meetings. Individuals registering for public 
comment should submit a copy of their oral testimony in advance to 
cfsac@hhs.gov, prior to the close of business on Wednesday, October 26, 
2011. If you wish to remain anonymous, please notify the CFSAC support 
team staff upon submission of your materials to cfsac@hhs.gov.
    If you do not submit your written testimony by the close of 
business Wednesday, October 26, 2011, you may bring a copy to the 
meeting and present it to a CFSAC support team staff member. Your 
testimony will be included in a notebook available for viewing by the 
public on a table at the back of the meeting room.
    Individuals who do not provide public comment at the meeting, but 
who wish to have printed material distributed to CFSAC members for 
review should submit, at a minimum, one copy of the material to the 
Designated Federal Officer at cfsac@hhs.gov prior to close of business 
on Wednesday, October 26, 2011. Submitted documents should be limited 
to five typewritten pages. If you wish to remain anonymous, please 
notify the CFSAC support team staff upon submitting your materials to 
cfsac@hhs.gov.
    All testimony and printed material submitted for the meeting are 
part of the official meeting record and will be uploaded to the CFSAC 
Web site; this material will be made available for public inspection. 
Testimony and materials submitted should not include any sensitive 
personal information, such as a person's social security number; date 
of birth; driver's license number, State identification number or 
foreign country equivalent; passport number; financial account number; 
or credit or debit card number. Sensitive health information, such as 
medical records or other personal identifiable health information, or 
any non-public corporate or trade association information, such as 
trade secrets or other proprietary information also should be excluded 
from any materials submitted.

    Dated: September 30, 2011.
Nancy C. Lee,
Designated Federal Officer, Chronic Fatigue Syndrome Advisory 
Committee.
[FR Doc. 2011-25739 Filed 10-4-11; 8:45 am]
BILLING CODE 4150-42-P